We are very happy to have closed our investment round! Many thanks to everyone who has supported us and everyone who has shown interest in our company.
New investors coming in are Scale Up Life Science Invest, Optiga, and Arcandis. Backed up by our solid investors Länsförsäkringar Uppsala, UU Invest, LiU Invest, and SLU Holding.
MyCurals CEO Alina Castell:
“We are delighted to have secured funding to support our Drug Development program. This will speed up the optimization of our lead molecule with the aim to nominate a candidate drug. Speed is very important for us bescause patients with agressive high-risk tumors don’t have any adequate treatments. We aim to bring forward a therapy that is milder and more efficient than previous treatments, and most of all, curative.”
